Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 7, 2018

View Archived Issues

Retinoic acid has role in fragile X

RNA delivery improves CF symptoms

miRNA-126 and miRNA-223 found significantly increased in cardiac sarcoidosis

Hypermethylation variant silences BRCA1 gene

Upregulation of transgelin-2 by KRAS gene mutation contributes to pancreatic cancer development

Almac, Elasmogen and Innovate UK to develop VNAR-based oncology platform

Final results from PROPEL study support further clinical development of PTG-100 in UC

MediciNova, University of Cambridge to study ibudilast in degenerative cervical myelopathy

Researchers discover potent and selective histone deacetylase 11 inhibitors

First patient treated in phase I of HPN-424 in metastatic castration-resistant prostate cancer

Ovid Therapeutics reports topline data from STARS study in Angelman syndrome

Topical curcumin nanocarriers provide retinal protection in preclinical eye disease models

Aevitas Therapeutics, University of Pennsylvania enter sponsored research agreement

Mebias Discovery patents new compounds for pain

Lundbeck's Lu-AF82422 for Parkinson's enters the clinic

Japanese researchers synthesize new analgesic drugs

Angiochem reaches agreement on design of phase III study of ANG-1005

Novel long-range PCR method allows Ebola virus genome sequencing from ecological or clinical samples

NanoViricides' topical dermal shingles drug candidates show efficacy in rat model

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 8, 2026.
New York University identifies new analogues of mannose-6-phosphate
BioWorld Science
New York University has discovered new analogues of mannose-6-phosphate reported to be potentially useful for the treatment of memory impairment,...
ASCO 2026: Chinese biopharma arrives at ASCO with pivotal wins
BioWorld
If the 2026 American Society of Clinical Oncology (ASCO) annual meeting in Chicago from May 30 to June 3 demonstrated anything about the evolution of China’s...
Bial-Portela discovers new OX1 receptor antagonists
BioWorld Science
Bial-Portela & Ca SA has patented new orexin OX1 receptor antagonists potentially useful for the treatment of anxiety disorders, depression, eating disorders,...
FB-7033 demonstrates efficacy in MASH management
BioWorld Science
17-β-Hydroxysteroid dehydrogenase 13 (HSD17B13) and lipid transferase CIDEB are known to contribute to metabolic dysfunction-associated steatohepatitis (MASH)...